Clinical trial NCT00306969 - References

Cutaneous T-Cell Lymphoma — Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma

Citation(s)

•   Duvic M, Martin AG, Kim Y, Olsen E, Wood GS, Crowley CA, Yocum RC; Worldwide Bexarotene Study Group
  Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol. 2001 May;137(5):581-93.
•   Girardi M, Heald PW, Wilson LD
  The pathogenesis of mycosis fungoides. N Engl J Med. 2004 May 6;350(19):1978-88. Review.

Phase I/II Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma

Details for clinical trial NCT00306969